Medical device immunity: should promotion of off-label uses leave medical device manufacturers vulnerable to unlimited liability?
作者信息
Palmer Phillip G
出版信息
J Leg Med. 2014;35(4):553-77. doi: 10.1080/01947648.2014.981489.
PMID:25517635
Abstract
摘要
相似文献
1
Medical device immunity: should promotion of off-label uses leave medical device manufacturers vulnerable to unlimited liability?医疗器械豁免：推广医疗器械的非标签使用是否会使制造商面临无限责任风险？
J Leg Med. 2014;35(4):553-77. doi: 10.1080/01947648.2014.981489.
2
3
Off-label use of medical devices in radiology: regulatory standards and recent developments.医疗器械在放射科的超适应证使用：监管标准和最新进展。
J Am Coll Radiol. 2010;7(2):115-9. doi: 10.1016/j.jacr.2009.09.025.
4
Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.药品和医疗器械：美国食品药品监督管理局监管。年终问题简报。
Issue Brief Health Policy Track Serv. 2010 Jan 4:1-31.
5
Off-label use of medical products in radiation therapy: summary of the report of AAPM Task Group No. 121.医学产品在放射治疗中的标签外使用：AAPM 工作组第 121 号报告的总结。
Med Phys. 2010 May;37(5):2300-11. doi: 10.1118/1.3392286.
6
A pivotal medical-device case.
N Engl J Med. 2008 Apr 17;358(16):1758. doi: 10.1056/NEJMc080148.
7
Ejecting the FDA from the courtroom.将美国食品药品监督管理局逐出法庭。
Lancet. 2004;364(9435):638. doi: 10.1016/S0140-6736(04)16905-5.
8
Origins of the prohibition against off-label promotion.禁止药品标签外推广的起源。
Food Drug Law J. 2014;69(2):161-236, i.
9
King v. Collagen Corporation: FDA approval insulates medical device manufacturers from state common law liability.金诉胶原蛋白公司案：美国食品药品监督管理局的批准使医疗器械制造商免受州普通法责任的追究。
J Contemp Health Law Policy. 1995 Spring;11(2):563-87.
10
The FDA, preemption, and the Supreme Court.美国食品药品监督管理局、优先适用权与最高法院。
N Engl J Med. 2008 May 1;358(18):1883-5. doi: 10.1056/NEJMp0802108.
Zotero 插件